Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Response Genetics, Inc. market cap is N/A.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Response Genetics, Inc. 52 week high is $0.0077 as of April 26, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Response Genetics, Inc. 52 week low is $0.0015 as of April 26, 2024.
Response Genetics, Inc. stock price today is $0.0033.
Response Genetics, Inc. stock price yesterday was $0.0024.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Response Genetics, Inc.’s P/E ratio is None.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Response Genetics, Inc. P/B ratio is None.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Response Genetics, Inc.'s EBITDA is N/A.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Response Genetics, Inc. 50-day moving average is $0.0024.
Response Genetics, Inc. has N/A employees.